drugset / Trial / NCT00875420

A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women

NCT00875420

Phase 2 Completed 100 enrolled Radius Pharmaceuticals, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether RAD1901 is effective in decreasing hot flashes in postmenopausal women.

Timeline

Start
2009-03
Primary completion
2010-01
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Elacestrant Other / unclassified 10 mg Oral
Subject Elacestrant Other / unclassified 25 mg Oral
Subject Elacestrant Other / unclassified 50 mg Oral
Subject Elacestrant Other / unclassified 100 mg Oral

Indications

No indication recorded.